Bukari Abdallah, Nayak Hemal, Aziz Zaid, Deshmukh Amrish, Tung Roderick, Ozcan Cevher
Department of Medicine, University of Chicago, Chicago, IL, USA.
Section of Cardiology, University of Chicago, Chicago, IL, USA.
Pacing Clin Electrophysiol. 2017 Oct;40(10):1073-1079. doi: 10.1111/pace.13165. Epub 2017 Sep 20.
Radiofrequency catheter ablation (CA) is an effective treatment of drug-refractory atrial fibrillation (AF). However, the efficacy of CA by race and gender has not been well characterized. We sought to determine the impact of ethnicity and gender on clinical outcome following CA in patients with AF.
Patients who underwent CA for AF from September 2013 to April 2016 were included in this study. Patients were identified retrospectively and followed prospectively.
A total of 118 patients (15.3% black and 78.8% white, 33% female) comprised the cohort, with mean age at ablation 63.4 ± 10.4 years. Black patients were older at time of the procedure (65.4 vs 63.4 years old) and had more prevalent comorbidities, including hypertension (77.8% vs 63.4%), diabetes (33.3% vs 15.0%), chronic kidney disease (22.2% vs 7.5%), and lower left ventricular ejection fraction (51.8% vs 56.2%). Blacks also had significantly larger left atrial size (P = 0.03). Late recurrence of AF was similar between blacks and whites (33.3% vs 34.4%, P = 1) as well as between women and men (28.2% vs 36.7%, P = 0.41). Early recurrence was predictive of late recurrence in men (P < 0.001) but not in women (P = 0.48). Enlarged left atrium and early recurrence of AF were significant predictors for late recurrence of AF in the cohort.
CA for AF is equally effective in black patients despite more prevalent comorbidity and increased left atrial size. Early recurrence of AF after CA was not predictive of late recurrence of AF in women but was in men.
射频导管消融术(CA)是治疗药物难治性心房颤动(AF)的有效方法。然而,CA在不同种族和性别的疗效尚未得到充分描述。我们试图确定种族和性别对AF患者CA术后临床结局的影响。
本研究纳入了2013年9月至2016年4月期间接受AF-CA治疗的患者。对患者进行回顾性识别并前瞻性随访。
该队列共纳入118例患者(15.3%为黑人,78.8%为白人,33%为女性),消融时的平均年龄为63.4±10.4岁。黑人患者手术时年龄较大(65.4岁对63.4岁),合并症更普遍,包括高血压(77.8%对63.4%)、糖尿病(33.3%对15.0%)、慢性肾脏病(22.2%对7.5%),且左心室射血分数较低(51.8%对56.2%)。黑人患者的左心房尺寸也显著更大(P=0.03)。AF的晚期复发在黑人和白人之间相似(33.3%对34.4%,P=1),在女性和男性之间也相似(28.2%对36.7%,P=0.41)。早期复发可预测男性的晚期复发(P<0.001),但不能预测女性的晚期复发(P=0.48)。左心房增大和AF早期复发是该队列中AF晚期复发的重要预测因素。
尽管黑人患者合并症更普遍且左心房尺寸增大,但AF-CA对他们同样有效。CA术后AF的早期复发不能预测女性的晚期复发,但可预测男性的晚期复发。